SE431653B - Forfarande for framstellning av 2,3-dihydro-imidazo/2,1-b/tiazolderivat - Google Patents

Forfarande for framstellning av 2,3-dihydro-imidazo/2,1-b/tiazolderivat

Info

Publication number
SE431653B
SE431653B SE7702503A SE7702503A SE431653B SE 431653 B SE431653 B SE 431653B SE 7702503 A SE7702503 A SE 7702503A SE 7702503 A SE7702503 A SE 7702503A SE 431653 B SE431653 B SE 431653B
Authority
SE
Sweden
Prior art keywords
tiazold
imidazo
dihydro
derivatives
preparing
Prior art date
Application number
SE7702503A
Other languages
English (en)
Other versions
SE7702503L (sv
Inventor
J L E Baetz
Original Assignee
Metabio Joullie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabio Joullie Sa filed Critical Metabio Joullie Sa
Publication of SE7702503L publication Critical patent/SE7702503L/sv
Publication of SE431653B publication Critical patent/SE431653B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7702503A 1976-03-10 1977-03-07 Forfarande for framstellning av 2,3-dihydro-imidazo/2,1-b/tiazolderivat SE431653B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9517/76A GB1541321A (en) 1976-03-10 1976-03-10 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
SE7702503L SE7702503L (sv) 1977-09-11
SE431653B true SE431653B (sv) 1984-02-20

Family

ID=9873507

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702503A SE431653B (sv) 1976-03-10 1977-03-07 Forfarande for framstellning av 2,3-dihydro-imidazo/2,1-b/tiazolderivat

Country Status (28)

Country Link
US (1) US4110460A (sv)
JP (1) JPS5927357B2 (sv)
AT (1) AT352716B (sv)
AU (1) AU503912B2 (sv)
BE (1) BE852259A (sv)
BG (1) BG28262A3 (sv)
CA (1) CA1074324A (sv)
CH (1) CH598267A5 (sv)
CS (1) CS190341B2 (sv)
DE (1) DE2709639A1 (sv)
DK (1) DK144702C (sv)
ES (1) ES456575A1 (sv)
FI (1) FI62313C (sv)
FR (1) FR2343748A1 (sv)
GB (1) GB1541321A (sv)
HU (1) HU172685B (sv)
IE (1) IE44280B1 (sv)
IL (1) IL51581A (sv)
LU (1) LU76879A1 (sv)
NL (1) NL7702446A (sv)
NO (1) NO150884C (sv)
PL (1) PL102603B1 (sv)
PT (1) PT66278B (sv)
RO (1) RO71301A (sv)
SE (1) SE431653B (sv)
SU (1) SU629882A3 (sv)
YU (1) YU61977A (sv)
ZA (1) ZA771303B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4204067A (en) * 1976-09-24 1980-05-20 Adhikary Parimal K Derivatives of imidazo[2,1-b] thiazole
US4263311A (en) * 1976-09-27 1981-04-21 Smithkline Corporation 5,6-Phenyl-2,3-dihydroimidazo [2,1-b] thiazoles
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
US4153706A (en) 1978-02-13 1979-05-08 Smithkline Corporation 6-Hydroxy-5,6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
PL221188A1 (sv) * 1979-01-05 1980-12-01 Ciba Geigy Ag
US4364942A (en) * 1979-06-21 1982-12-21 Janssen Pharmaceutica N.V. 2,3-Dihydro-imidazo (2,1-b)benzothiazoles compositions useful as anti-parkinsonism agents
FR2463774A1 (fr) * 1979-08-21 1981-02-27 Yamanouchi Pharma Co Ltd Derives du 2-phenylimidazo(2,1-b)benzothiazole
FR2479831A1 (fr) * 1980-04-08 1981-10-09 Synthelabo Derives de thiazole, leur preparation et leur application en therapeutique
US4327221A (en) * 1980-10-15 1982-04-27 American Home Products Corporation 2-Substituted-3-hydroxythiazolo(2,3-8)-thiazolium salts and mesoionic didehydro derivatives thereof
US4719218A (en) * 1985-12-12 1988-01-12 Smithkline Beckman Corporation Pyrrolo[1,2-a]imidazole and pyrrolo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitor
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US5145858A (en) * 1985-12-12 1992-09-08 Smithkline Beecham Corp. Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US4751310A (en) * 1985-12-12 1988-06-14 Smithkline Beckman Corporation Inhibition of the 5-lipoxygenase pathway
US5134150A (en) * 1985-12-12 1992-07-28 Smithkline Beecham Corporation Inhibition of the 5-lipoxygenase pathway
ZW24186A1 (en) * 1985-12-12 1987-07-08 Smithkline Beckman Corp Inhibition of the 5-lipoxygenase pathway
US4794114A (en) * 1986-08-19 1988-12-27 Smithkline Beckman Corporation Inhibition of interleukin-1 production by monocytes and/or macrophages
US5630014A (en) * 1993-10-27 1997-05-13 Nec Corporation Gain controller with automatic adjustment using integration energy values
US6127387A (en) * 1996-12-10 2000-10-03 Thomas Jefferson University Use of CD4-binding small molecules to inhibit immune responses
WO2007034282A2 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (sv) * 1964-05-11
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles
NL164285C (nl) * 1968-01-09 1980-12-15 Rhone Poulenc Sa Werkwijze ter bereiding van een farmaceutisch preparaat, dat een imidazoÿ2.1-bÿthiazoolderivaat bevat, de gevormde farmaceutische preparaten, alsmede werkwijze voor het bereiden van dit imidazoÿ2.1-bÿthiazoolderivaat.

Also Published As

Publication number Publication date
DK104677A (da) 1977-09-11
YU61977A (en) 1982-06-30
IE44280B1 (en) 1981-09-23
FI62313C (fi) 1982-12-10
NO150884B (no) 1984-09-24
GB1541321A (en) 1979-02-28
DE2709639A1 (de) 1977-09-15
SU629882A3 (ru) 1978-10-25
ES456575A1 (es) 1978-02-16
JPS5927357B2 (ja) 1984-07-05
DK144702B (da) 1982-05-17
NO150884C (no) 1985-01-09
FI62313B (fi) 1982-08-31
ZA771303B (en) 1978-01-25
JPS52136195A (en) 1977-11-14
PT66278B (fr) 1978-08-08
AT352716B (de) 1979-10-10
NO770841L (no) 1977-09-13
FI770759A (sv) 1977-09-11
US4110460A (en) 1978-08-29
PT66278A (fr) 1977-04-01
DK144702C (da) 1982-10-11
CH598267A5 (sv) 1978-04-28
PL102603B1 (pl) 1979-04-30
LU76879A1 (sv) 1977-07-12
BE852259A (fr) 1977-09-09
IL51581A0 (en) 1977-05-31
AU503912B2 (en) 1979-09-27
SE7702503L (sv) 1977-09-11
CA1074324A (en) 1980-03-25
BG28262A3 (en) 1980-03-25
NL7702446A (nl) 1977-09-13
CS190341B2 (en) 1979-05-31
RO71301A (ro) 1981-11-24
IE44280L (en) 1977-09-10
HU172685B (hu) 1978-11-28
FR2343748B1 (sv) 1980-07-18
FR2343748A1 (fr) 1977-10-07
ATA164477A (de) 1979-03-15
AU2315677A (en) 1978-09-14
IL51581A (en) 1980-02-29

Similar Documents

Publication Publication Date Title
SE431653B (sv) Forfarande for framstellning av 2,3-dihydro-imidazo/2,1-b/tiazolderivat
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
AR224095A1 (es) Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3
FR2303016A1 (fr) Derives de (1,5-a) (1,4)-diazepine
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
AR220675A1 (es) Procedimiento para la preparacion de derivados sustituidos de pirido(1,2-a)pirimidinas
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO147423C (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater.
SE7707125L (sv) Forfarande for framstellning av 7-(alfa-(2,3, - dihydro-2-oxo-1h- bensimidazol -1- ylkarbomyl-amino) arylacetamido ) cefalasporiner
MX5340E (es) Procedimiento para preparar derivados de hexahidro 1,2,3,3a.4,5-oxo-6-6h-indolo(3,2,1-de)naftiridina
SE426947B (sv) Forfarande for framstellning av 3,5,5-trimetyl-hexanoyl-ferrocen
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE431647B (sv) Forfarande for framstellning av 2-nitroimidazolderivat
SE422940B (sv) Forfarande for framstellning av 3,3,4,4-teraklortetrahydrotiofen-1,1-dioxid
SE422207B (sv) Forfarande for framstellning av 1,4-bensodiazepinderivat